Factors associated with resolution of type-2 diabetes mellitus after sleeve gastrectomy in obese adults

Many bariatric procedures are more effective for improving type-2 diabetes mellitus (T2DM) than conventional pharmacotherapy. The current research evaluated factors linked to complete and partial remission or improvement of T2DM after laparoscopic sleeve gastrectomy (LSG). The current prospective study included all diabetic patients who were submitted LSG between January 2015 and June 2018 and completed a 2-year follow-up period. Patients were assessed at baseline and 2 years after LSG. This work comprised of 226 diabetic cases. Two years after LSG, 86 patients (38.1%) achieved complete remission of DM, and 24 (10.6%) reached partial remission. Only 14 patients (6.2%) showed no change in their diabetic status. On univariate analysis, age <= 45 years, duration of diabetes <= 5 years, use of a single oral antidiabetic, HbA1c <= 6.5%, HOMA-IR <= 4.6, C-peptide>2.72 ng/mL, and BMI <= 40 kg/m(2) predicted complete remission. The independent predictors of complete remission were age <= 45 years, duration of diabetes <= 5 years, use of a single oral antidiabetic, HOMA-IR <= 4.6, and C-peptide>2.72 ng/mL. A combined marker of young age, short duration of DM, and low HOMA-IR predicted complete remission with sensitivity 93% and specificity 82%. Independent predictors of complete remission of T2DM after LSG were younger age, shorter duration, single oral antidiabetic, lower HOMA-IR, and higher C-peptide.